US2014011771A1PendingUtilityA1

S1p3 receptor inhibitors for treating pain

Assignee: ALLERGAN INCPriority: May 8, 2007Filed: Sep 4, 2013Published: Jan 9, 2014
Est. expiryMay 8, 2027(~0.8 yrs left)· nominal 20-yr term from priority
C07F 9/58C07D 401/06A61K 31/404C07D 209/42A61P 29/00A61K 31/44A61K 31/662A61P 29/02A61K 31/00Y02A50/30C07F 9/585C07F 9/588
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are compositions and methods for treating pain using S1P3 receptor inhibitors.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for treating pain, the method comprising the step of administering to a patient in need of such treatment at least one compound selected from the group consisting of: 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof. 
       
     
     
         2 . A method for treating pain, the method comprising the step of administering to a patient in need of such treatment at least one compound selected from the group consisting of: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2014011771A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.